type 1 diabetes

JDRF Disappointed by UnitedHealthcare’s Preferred Medtronic Insulin Pump
JDRF Disappointed by UnitedHealthcare’s Preferred Medtronic Insulin Pump
Xtalks
type 1 diabetes
JDRF
Medtronic
devices
MiniMed 670G
UnitedHealthcare
Flag link:
AstraZeneca’s Forxiga recommended for marketing authorization in EU
AstraZeneca’s Forxiga recommended for marketing authorization in EU
Pharmaceutical Business Review
EMA
AstraZeneca
Forxiga
type 1 diabetes
CHMP
Flag link:
U.S. insulin costs per patient nearly doubled from 2012 to 2016: study
U.S. insulin costs per patient nearly doubled from 2012 to 2016: study
Reuters
insulin
drug pricing
type 1 diabetes
Flag link:
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Pharmaforum
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
Zynquista
FDA
advisory panels
sotagliflozin
Flag link:
Daiichi Sankyo takes option on diabetes stem cell start-up
Daiichi Sankyo takes option on diabetes stem cell start-up
Pharmaforum
Daiichi Sankyo
stem cells
Tokyo Institute of Technology
type 1 diabetes
OiDE BetaRevive
Flag link:
A vaccine for Type 1 diabetes? Provention Bio says a human trial is in sight
A vaccine for Type 1 diabetes? Provention Bio says a human trial is in sight
Fierce Biotech
type 1 diabetes
Provention Bio
vaccines
PRV-101
Flag link:
Eli Lilly's diabetes treatment meets main goal in two late-stage studies
Eli Lilly's diabetes treatment meets main goal in two late-stage studies
Reuters
Eli Lilly
Ultra Rapid Lispro
Humalog
diabetes
type 1 diabetes
type 2 diabetes
Flag link:
New Therapy Could Reverse Type 1 Diabetes In Humans And Dogs
New Therapy Could Reverse Type 1 Diabetes In Humans And Dogs
Forbes
type 1 diabetes
animal health
diabetes
collagen
Flag link:
Pfizer drops diabetes and cancer drugs from clinical pipeline
Pfizer drops diabetes and cancer drugs from clinical pipeline
Fierce Biotech
Pfizer
PF-06342674
PF-06747775
type 1 diabetes
Flag link:
Controversial researcher’s diabetes vaccine causes improvement in small study
Controversial researcher’s diabetes vaccine causes improvement in small study
Stat
type 1 diabetes
diabetes
clinical trials
insulin
vaccines
Organon Teknika
Flag link:
Beta receives FDA go-ahead for home trials of AI-guided bionic pancreas
Beta receives FDA go-ahead for home trials of AI-guided bionic pancreas
Fierce Biotech
Beta Bionics
FDA
bionic pancreas
artificial intelligence
devices
type 1 diabetes
Flag link:
Novo Nordisk steps up interest in diabetes, Parkinson’s stem cell therapies
Novo Nordisk steps up interest in diabetes, Parkinson’s stem cell therapies
Fierce Biotech
Novo Nordisk
type 1 diabetes
stem cells
Flag link:
Citing significant progress on a cure for diabetes, Novo Nordisk beefs up its stem cell pipeline with new collaborations
Citing significant progress on a cure for diabetes, Novo Nordisk beefs up its stem cell pipeline with new collaborations
Endpoints
Novo Nordisk
type 1 diabetes
stem cells
Biolamina
Flag link:
How Bigfoot Biomedical’s CEO wants to boost diabetes management
How Bigfoot Biomedical’s CEO wants to boost diabetes management
Medical Design and Outsourcing
Jeffrey Brewer
type 1 diabetes
Bigfoot Biomedical
devices
Flag link:
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Drug Delivery Business News
Eli Lilly
Sigilon
cell therapies
drug development
type 1 diabetes
Flag link:
10 Events that Rattled Medtech in 1Q18
10 Events that Rattled Medtech in 1Q18
Medical Devices and Diagnostics Industry
devices
InMode
Votiva
JNJ
diabetes
LifeScan
Orthotaxy
robotic surgery
Abbott Labs
HeartMate 3
Medtronic
Guardian Sensor 3
Edwards Lifesciences
Centera valve
SFC Fluidics
EOFlow Co
type 1 diabetes
Boston Scientific
FDA
duodenoscope
PENTAX
Fujifilm
Olympus
Theranos
Elizabeth Holmes
Flag link:
Sanofi/Lexicon’s sotagliflozin filed in US and EU for type 1 diabetes
Sanofi/Lexicon’s sotagliflozin filed in US and EU for type 1 diabetes
Pharmaforum
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
sotagliflozin
Flag link:
Looking to cure Type 1 diabetes, investors front $114M to launch a pioneering human study at Semma
Looking to cure Type 1 diabetes, investors front $114M to launch a pioneering human study at Semma
Endpoints
type 1 diabetes
Semma Therapeutics
Flag link:
Powerful new cancer drugs are saving lives, but can also ignite diabetes or other autoimmune conditions
Powerful new cancer drugs are saving lives, but can also ignite diabetes or other autoimmune conditions
Science
cancer
checkpoint inhibitors
autoimmune disease
type 1 diabetes
Flag link:
First Oral Drug for Type 1 Diabetes Could be Available in 2018
First Oral Drug for Type 1 Diabetes Could be Available in 2018
Xtalks
type 1 diabetes
sotagliflozin
Sanofi
Lexicon Pharmaceuticals
Flag link:

Pages